Cell Surgical Network Study for Stromal Vascular Fraction Registered by ClinicalTrials.gov

Rancho Mirage, CA (PRWEB) October 14, 2013 Clinicaltrials.gov, a service of the U.S. National Institutes of Health has registered on their public site an IRB approved safety study from the Cell Surgical Network, Inc.. This study is available for patients with various degenerative and inflammatory conditions to undergo Stromal Vascular Fraction deployment for the evaluation and for the…

Parkinson’s disease and stem cells.

2011 Jan; 1812(1) : 1-11. Epub 2010 Aug 14. Stem cell potential in Parkinson’s disease and molecular factors for the generation of dopamine neurons. Kim HJ. Abstract Parkinson’s disease (PD) involves the loss of dopamine (DA) neurons, making it the most expected neurodegenerative disease to be treated by cell replacement therapy. Stem cells are a…

Implications for cell based therapies in Parkinson’s.

Biol Blood Marrow Transplant. 2010 Nov; 16(11) : 1530-40. Epub 2010 Jun 10. Intranigral transplantation of epigenetically induced BDNF-secreting human mesenchymal stem cells: implications for cellbased therapies in Parkinson’s disease. Somoza R, Juri C, Baes M, Wyneken U, Rubio FJ. Institute of Science, Clinica Alemana Universidad del Desarrollo, Santiago, Chile. Abstract It is thought that…

Ageing and neurodegenerative diseases.

Ageing Res Rev. 2010 Nov; 9 Suppl 1 : S36-46. Epub 2010 Aug 21. Ageing and neurodegenerative diseases. Hung CW, Chen YC, Hsieh WL, Chiou SH, Kao CL. Department of Neurology, Zhongxiao Branch, Taipei City Hospital/No 87, Tongde Rd, Nangang Dist, Taipei City 115, Taiwan. Abstract Ageing, which all creatures must encounter, is a challenge…

Stem cells and neurological diseases.

Gene Ther. 2010 Sep 30. [Epub ahead of print] Progress and prospects: stem cells and neurological diseases. Gögel S, Gubernator M, Minger SL. Wolfson Centre for Age-Related Diseases, Guy’s Campus, King’s College London, London, UK. Abstract The central nervous system has limited capacity of regenerating lost tissue in slowly progressive, degenerative neurological conditions such as…

Dopaminergic neuronal cells in Parkinson’s model rats.

Neurosurg. 2010 Sep; 113(3) : 648-55. Skin-derived precursors differentiating into dopaminergic neuronal cells in the brains of Parkinson disease model rats. Higashida T, Jitsuki S, Kubo A, Mitsushima D, Kamiya Y, Kanno H. Department of Neurosurgery, Yokohama City University, School of Medicine, Yokohama, Kanagawa, Japan. tets018@gmail.com Abstract OBJECT: In the authors’ previous study, they observed…

Stem cells promote recovery in a rat model of Parkinson’s disease.

J Neurosci Res. 2010 Sep; 88(12) : 2669-81. Glial cell line-derived neurotrophic factor-secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson’s disease. Glavaski-Joksimovic A, Virag T, Mangatu TA, McGrogan M, Wang XS, Bohn MC. Department of Pediatrics, Neurobiology Program, Children’s Memorial Research Center, Feinberg School of Medicine,…

Translation of stem cell therapy for neurological diseases.

Transl Res. 2010 Sep; 156(3) : 155-60. Epub 2010 Jul 23. Translation of stem cell therapy for neurological diseases. Schwarz SC, Schwarz J. Department of Neurology, University of Leipzig, Leipzig, Germany. Abstract “Regenerative medicine” hopefully will provide novel therapies for diseases that remain without effective therapy. This development is also true for most neurodegenerative disorders…